Last update 06 Nov 2024

Siplizumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Siplizumab (USAN/INN), MEDI-507, TCD 601
+ [2]
Target
Mechanism
CD2 inhibitors(T-cell surface antigen CD2 inhibitors)
Active Organization
Itbmed ABItbmed ABStartup
Drug Highest PhasePhase 2
First Approval Date-
RegulationOrphan Drug (US), Orphan Drug (EU)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D05847Siplizumab-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anemia, Sickle CellPhase 2
US
Itbmed ABItbmed ABStartup
28 Sep 2023
Diabetes Mellitus, Type 1Phase 2
BE
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
FR
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
DE
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
IT
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
PL
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
ES
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
SE
Itbmed ABItbmed ABStartup
23 Jan 2023
Diabetes Mellitus, Type 1Phase 2
GB
Itbmed ABItbmed ABStartup
23 Jan 2023
Plaque psoriasisPhase 2
US
01 Mar 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
2
Thymic Irradiation+MEDI-507+Rituximab
vbvxqlfosw(tirzwxfyuh) = xdehxyntlg uhzwbdvixs (iudsfnhazr, wetdlhqigx - asidgkqwgo)
-
23 Sep 2020
Phase 1
-
gdfrtwunhc(nwbavqlyta) = tzahpmeuga lggmavpneg (tzchbfdtzi )
-
03 Jun 2018
Phase 2
5
rituximab+MEDI-507+methylprednisolone+Cyclophosphamide+Prednisone+tacrolimus+steroid
lbexwmnyyz(txjhopvhmd) = ctpgzkgigq adrwnkmedb (vxnjlkudhb, qdmkzcojeg - gyksjtqinz)
-
12 May 2015
Phase 1
9
dgqhitwkhz(ykncqkdjsa) = kukthpybga plznohtqth (knixtpjymk, 24–99)
-
01 Jun 2005
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free